21. De Novo Malignancies in 1639 Consecutive Living Donor Liver Transplant Recipients: An Experience from India.

Highlights from the article: B Background and Aims: b Liver recipients like all organ transplant recipients, have a risk of developing denovo malignancies due to prolonged immunosuppression. B Results: b Of 1639 patients who underwent LDLT, 20 (1.22%) developed de novo malignancy after transplantation, among which 19 were males and 1 female. Of 20 de novo malignancies, 6 had oropharyngeal malignancy (carcinoma of oral and buccal mucosa), 4 lung cancer, 2 squamous cell carcinoma of skin, 2 lymphoma and 1 each had hepatoblastoma, bone tumor, carcinoma stomach; carcinoma ovary, pancreatic cancer and prostate cancer.